A Bioavailability Study of Nilotinib in Healthy, Adult, Human Subjects Under Fasted Conditions.
Clinical trial NCT07138378 · COMPLETED
Trial details
- NCT number
- NCT07138378
- Sponsor
- Xspray Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2024-12-15
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.